Marc Feldmann
Impact in
- Immunology top 0.01%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Papers in
- Immunology 326
- T-cell and B-cell Immunology 170
- Immune Cell Function and Interaction 129
- Immunotherapy and Immune Responses 107
- Immune Response and Inflammation 96
- Rheumatology 133
- Rheumatoid Arthritis Research and Therapies 103
- Systemic Lupus Erythematosus Research 54
- Co-authors
- Ravinder Nath Maini (89 shared papers)Fionula M. Brennan (99 shared papers)Richard O. Williams (44 shared papers)Michael J. Elliott (14 shared papers)Claudia Gianini Monaco (25 shared papers)Marco Londei (45 shared papers)Ferdinand C. Breedveld (4 shared papers)Brian M. J. Foxwell (29 shared papers)
- Journals
- European Journal of Immunology (44 papers)The Journal of Immunology (35 papers)Proceedings of the National Academy of Sciences (25 papers)The Journal of Experimental Medicine (21 papers)Nature (20 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Marc Feldmann
581 papers receiving 55.9k citations
Marc Feldmann's Hit Papers
Peers
Comparison fields: 5 of 189
- Immunology 23.6k
- Rheumatology 14.9k
- Immunology and Allergy 3.0k
- Hematology 4.4k
- Radiology, Nuclear Medicine and Imaging 7.2k
Countries citing papers authored by Marc Feldmann
This map shows the geographic impact of Marc Feldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Feldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Feldmann more than expected).
Fields of papers citing papers by Marc Feldmann
This network shows the impact of papers produced by Marc Feldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Feldmann. The network helps show where Marc Feldmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Feldmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 592 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis Hit paper breakdown → | 2000 | 2620 |
| 2 | ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS Hit paper breakdown → | 1996 | 2243 |
| 3 | Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial Hit paper breakdown → | 1999 | 2039 |
| 4 | An inflammatory cytokine signature predicts COVID-19 severity and survival Hit paper breakdown → | 2020 | 1899 |
| 5 | Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis Hit paper breakdown → | 1994 | 1452 |
| 6 | Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Hit paper breakdown → | 1998 | 1417 |
| 7 | ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY Hit paper breakdown → | 1983 | 1137 |
| 8 | IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses Hit paper breakdown → | 2011 | 1107 |
| 9 | Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned? Hit paper breakdown → | 2001 | 1096 |
| 10 | Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α Hit paper breakdown → | 1993 | 911 |
| 11 | Rheumatoid Arthritis Hit paper breakdown → | 1996 | 910 |
| 12 | Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Hit paper breakdown → | 1992 | 872 |
| 13 | Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis Hit paper breakdown → | 1988 | 713 |
| 14 | Role of interleukin‐1β in postoperative cognitive dysfunction Hit paper breakdown → | 2010 | 641 |
| 15 | Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive decline Hit paper breakdown → | 2010 | 615 |
| 16 | Macrophage heterogeneity in the context of rheumatoid arthritis Hit paper breakdown → | 2016 | 582 |
| 17 | 2002 | 577 | |
| 18 | 2000 | 573 | |
| 19 | 1994 | 571 | |
| 20 | 1991 | 514 |
About Marc Feldmann
Marc Feldmann is a scholar working on Immunology, Rheumatology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Oncology, having authored 592 papers that have together received 60.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (170 papers), Monoclonal and Polyclonal Antibodies Research (139 papers), Immune Cell Function and Interaction (129 papers), Immunotherapy and Immune Responses (107 papers), Rheumatoid Arthritis Research and Therapies (103 papers), Immune Response and Inflammation (96 papers), Systemic Lupus Erythematosus Research (54 papers) and Cell Adhesion Molecules Research (53 papers). The work is most often cited by research in Immunology (23.6k citations), Rheumatology (14.9k citations), Immunology and Allergy (3.0k citations), Hematology (4.4k citations) and Radiology, Nuclear Medicine and Imaging (7.2k citations). Marc Feldmann has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Ravinder Nath Maini, Fionula M. Brennan, Richard O. Williams, Michael J. Elliott, Claudia Gianini Monaco, Marco Londei, Ferdinand C. Breedveld, Brian M. J. Foxwell, Josef S Smolen and Peter Charles Taylor. Their work appears in journals such as European Journal of Immunology, The Journal of Immunology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.